India now hosts over 150 such Healthcare and Life Sciences GCCs including R&D centers, Global Business Services, Shared Services, and Centres of Excellence employing more than three lakh professionals ...

India is seeking enhanced collaboration with Switzerland in research, biotechnology, and pharmaceuticals. This move aims to ...

Hyderabad: India's pharmaceutical industry is expected to remain anchored in generics and biosimilars through 2030, even as ...

With the US accounting for nearly 35% of India’s overall pharma shipments of over $30 billion in FY24-25, the move is expected to bolster growth prospects and pipeline visibility. A potential India-US ...

Feb 10 (Reuters) - Indian ‌drugmaker ​Lupin said ‌on Tuesday it has ​settled a patent infringement dispute ‍with Japan's ...

Sanofi has expanded its Hyderabad Global Capability Centre, raising capacity to 4,500 employees and deepening India's role in global pharma operations, AI, data science and innovation ...

Parthenon report says AI-led R&D is accelerating drug discovery and decision-making in India’s bio-pharma sector. From generative design to digital twins and LLM copilots, firms are building ...

On any given morning in Mumbai’s Shivaji Park, power-walkers circle the running track, fitness watches buzzing with every step. Minutes later, some drift toward nearby food stalls, where oil sizzles ...

NEW DELHI, Oct 14 (Reuters) - Indian authorities have accused Balaji Amines (BAMN.NS), opens new tab of producing pharmaceutical-grade propylene glycol without a drug manufacturing licence, after some ...

A JB Chemicals factory in Gujarat in western India. Torrent Pharmaceuticals—controlled by India billionaire brothers Sudhir and Samir Mehta—has agreed to buy U.S. private equity giant KKR’s stake in ...

India’s J.B. Chemicals and Pharmaceuticals is ready to fly the nest of private equity firm KKR, with Torrent Pharmaceuticals taking over KKR’s 46.39% controlling stake in the drugmaker for 119 billion ...